PHARMARIS is a business group with extensive experience in various areas of the health industry. Our client has entrusted us to represent them in an important process initiated by the company Sanofi, which is one of the most important pharmaceutical corporations in the world.
This process was filed by Sanofi to obtain the nullity of the sanitary registration of the product Glaritus (Insulin Glargine) distributed by PHARMARIS. This process is important because if the sanitary registration of the product Glaritus (Insulin Glargine) gets annulled, PHARMARIS would leave the market and Sanofi would obtain a monopoly in the distribution of insulin glargine in the Peruvian market. Indeed, when our client introduced his product to the market, the cost of insulin was reduced by 50%.
